Atrial Fibrillation
September 2018 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Atrial Fibrillation abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Atrial Fibrillation. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Atrial Fibrillation. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Atrial Fibrillation every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement.
Authors:Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB
Institution:University of Iowa, Iowa City.
Journal:JAMA. 2018 Aug 7;320(5):478-484. doi: 10.1001/jama.2018.10321.

2:Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Authors:Jonas DE, Kahwati LC, Yun JDY, Middleton JC, Coker-Schwimmer M, Asher GN
Institution:RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center. at Chapel Hill. Practice Center. at Chapel Hill. Practice Center. at Chapel Hill. Practice Center. at Chapel Hill. at Chapel Hill.
Journal:JAMA. 2018 Aug 7;320(5):485-498. doi: 10.1001/jama.2018.4190.

3:Long-term outcome of radiofrequency catheter ablation for persistent atrial fibrillation.
Authors:Yubing W, Yanping X, Zhiyu L, Weijie C, Li S, Huaan D, Peilin X, Zengzhang L, Yuehui Y
Institution:Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmia Service Center, Chongqing.; Affiliated Hospital of North Sichuan Medical College, Sichuan, China.
Journal:Medicine (Baltimore). 2018 Jul;97(29):e11520. doi: 10.1097/MD.0000000000011520.

4:Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis.
Authors:Mendoza-Sanchez J, Silva F, Rangel L, Jaramillo L, Mendoza L, Garzon J, Quiroga A
Institution:Grupo de Ciencias Neurovasculares, Instituto Neurologico, Hospital Internacional, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia.; Universidad Industrial de Santander, Bucaramanga, Santander, Colombia.
Journal:PLoS One. 2018 May 3;13(5):e0196361. doi: 10.1371/journal.pone.0196361. eCollection 2018.

5:Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
Authors:Lip GYH, Pan X, Kamble S, Kawabata H, Mardekian J, Masseria C, Phatak H
Institution:University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom. University, Aalborg, Denmark. (BMS), Princeton, New Jersey, United States of America. (BMS), Princeton, New Jersey, United States of America. (BMS), Princeton, New Jersey, United States of America. United States of America. United States of America. (BMS), Princeton, New Jersey, United States of America.
Journal:PLoS One. 2018 Apr 30;13(4):e0195950. doi: 10.1371/journal.pone.0195950. eCollection 2018.

6:Estimated prevalence of undiagnosed atrial fibrillation in the United States.
Authors:Turakhia MP, Shafrin J, Bognar K, Trocio J, Abdulsattar Y, Wiederkehr D, Goldman DP
Institution:Stanford University School of Medicine, Stanford, California, United States of America. California, Los Angeles, California, United States of America.
Journal:PLoS One. 2018 Apr 12;13(4):e0195088. doi: 10.1371/journal.pone.0195088. eCollection 2018.

7:Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
Authors:McHorney CA, Crivera C, Laliberte F, Germain G, Wynant W, Lefebvre P
Institution:Evidera, Bethesda, Maryland, United States of America.
Journal:PLoS One. 2018 Apr 5;13(4):e0194099. doi: 10.1371/journal.pone.0194099. eCollection 2018.

8:Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study.
Authors:Paciullo F, Proietti M, Bianconi V, Nobili A, Pirro M, Mannucci PM, Lip GYH, Lupattelli G
Institution:Unit of Internal Medicine, Department of Medicine, University of Perugia, Piazzale Menghini, Sant'Andrea delle Fratte, 06132, Perugia, Italy. University of Perugia, Perugia, Italy.
Journal:Drugs Aging. 2018 Apr;35(4):365-373. doi: 10.1007/s40266-018-0532-8.

9:Identifying Warfarin Control With Stroke and Bleed Risk Scores.
Authors:Bernaitis N, Ching CK, Badrick T, Anoopkumar-Dukie S
Institution:Menzies Health Institute and Quality Use of Medicines Network, Queensland, Griffith University, Brisbane, Qld, Australia; School of Pharmacy & Pharmacology, Griffith University, Brisbane, Qld, Australia. Griffith University, Brisbane, Qld, Australia; School of Pharmacy & Pharmacology, Griffith University, Brisbane, Qld, Australia. Electronic address: s.dukie@griffith.edu.au.
Journal:Heart Lung Circ. 2018 Jun;27(6):756-759. doi: 10.1016/j.hlc.2017.11.009. Epub 2017 Nov 28.

10:Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function.
Authors:Weir MR, Haskell L, Berger JS, Ashton V, Laliberte F, Crivera C, Brown K, Lefebvre P, Schein J
Journal:Clin Nephrol. 2018 May;89(5):314-329. doi: 10.5414/CN109281.

11:Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation.
Authors:Al-Kawaz M, Omran SS, Parikh NS, Elkind MSV, Soliman EZ, Kamel H
Institution:Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, New York; Department of Neurology, Weill Cornell Medicine, New York, New York. Electronic address: maa2067@nyp.org.; Department of Neurology, College of Physicians and Surgeons, Winston-Salem, North Carolina; Department of Epidemiology, Mailman School of Public Health, Columbia University, Winston-Salem, North Carolina.; Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Journal:J Stroke Cerebrovasc Dis. 2018 Apr;27(4):839-844. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.025. Epub 2017 Dec 6.

12:Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
Authors:Sobue Y, Watanabe E, Lip GYH, Koshikawa M, Ichikawa T, Kawai M, Harada M, Inamasu J, Ozaki Y
Institution:Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. sobue@fujita-hu.ac.jp.; City Hospital, University of Birmingham Institute of Cardiovascular Sciences, Birmingham, England, UK.; Department of Neurosurgery, Fujita Health University School of Medicine, Toyoake, Japan.
Journal:Heart Vessels. 2018 Apr;33(4):403-412. doi: 10.1007/s00380-017-1073-5. Epub 2017 Oct 24.

13:Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants.
Authors:Beshir SA, Aziz Z, Yap LB, Chee KH, Lo YL
Institution:Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Malaysia. Malaysia.
Journal:J Clin Pharm Ther. 2018 Apr;43(2):209-219. doi: 10.1111/jcpt.12634. Epub 2017 Oct 13.

14:Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
Authors:Femia G, Fetahovic T, Shetty P, Lee A
Institution:Department of Cardiology, The Wollongong Hospital, Wollongong, NSW, Australia. Electronic address: femia82@gmail.com.
Journal:Heart Lung Circ. 2018 Jul;27(7):798-803. doi: 10.1016/j.hlc.2017.06.726. Epub 2017 Jul 17.

15:Low prevalence of atrial fibrillation in Amerindians: a population-based study in frequent fish consumers living in rural coastal Ecuador (The Atahualpa Project).
Authors:Del Brutto OH, Costa AF, Cano JA, Penaherrera E, Plaza KJ, Ledesma EA, Tettamanti D, Zambrano M
Institution:School of Medicine, Universidad Espiritu Santo - Ecuador, Km 2.5 via Puntilla-Samborondon, Guayaquil, Ecuador. oscardelbrutto@hotmail.com. Puntilla-Samborondon, Guayaquil, Ecuador. Puntilla-Samborondon, Guayaquil, Ecuador. Puntilla-Samborondon, Guayaquil, Ecuador. Puntilla-Samborondon, Guayaquil, Ecuador.
Journal:Aging Clin Exp Res. 2018 May;30(5):539-542. doi: 10.1007/s40520-017-0810-z. Epub 2017 Jul 31.

16:Long-Term Results of Surgical Atrial Fibrillation Radiofrequency Ablation: Comparison of Two Methods.
Authors:Yang S, Mei B, Feng K, Lin W, Chen G, Liang M, Zhang X, Wu Z
Institution:The Second Cardiac Surgery Department of First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: wuzhk@mail.sysu.edu.cn.; The Cardiac Surgery Department of First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Journal:Heart Lung Circ. 2018 May;27(5):621-628. doi: 10.1016/j.hlc.2017.04.016. Epub 2017 May 24.

For a FREE PREVIEW of the Medifocus Guidebook on Atrial Fibrillation click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Atrial Fibrillation click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Atrial Fibrillation...
at a Special 20% Discount


Medifocus Guidebook on Atrial Fibrillation

Updated: July 2, 2018
247 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Atrial Fibrillation is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

AF63294691

Coupon Expires: January 13, 2019



What Our Customers Are Saying...

"The MediFocus Guidebook on Atrial Fibrillation has enhanced and clearly explained this condition for me. It has also enabled me to make choices with confidence regarding my treatment. The references in the medical literature section has put me in touch with the research base in this country. Many thanks."
E.B.
Seaford, East Sussex


"I found the MediFocus Guidebook on Atrial Fibrillation extremely informative and very easy to understand. As a result of the information in the Guidebook, I'm able to discuss my problem with my doctor in a more informed manner and make better decisions regarding treatment."
J.T.F.
Agoura Hills, California


"The Medifocus Guidebook on Atrial Fibrillation gave me far more information than was available from my doctor and helped me understand my condition."
C.B.
Rancho Santa Fe, California



  
Medifocus Digest Alert is published by Medifocus, Inc.
6810 Park Heights Avenue, Suite C5, Baltimore, MD 21215 USA
Copyright © 2018 Medifocus, Inc. All rights reserved.